These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31354964)

  • 1. Educational needs in gastrointestinal cancer: a consensus position paper from the ESMO Gastrointestinal Cancer Faculty.
    Lordick F; Obermannova R; Vola D; Douillard JY; Mcgregor K; Van Cutsem E; Tabernero J; Ciardiello F; Cervantes A
    ESMO Open; 2019; 4(3):e000533. PubMed ID: 31354964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical relevance of molecular diagnostics in gastrointestinal (GI) cancer: European Society of Digestive Oncology (ESDO) expert discussion and recommendations from the 17th European Society for Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona.
    Baraniskin A; Van Laethem JL; Wyrwicz L; Guller U; Wasan HS; Matysiak-Budnik T; Gruenberger T; Ducreux M; Carneiro F; Van Cutsem E; Seufferlein T; Schmiegel W
    Eur J Cancer; 2017 Nov; 86():305-317. PubMed ID: 29065378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO).
    Morgan G; Lambertini M; Kourie HR; Amaral T; Argiles G; Banerjee S; Cardone C; Corral J; De Mattos-Arruda L; Öztürk A; Petrova M; Poulsen L; Strijbos M; Tyulyandina A; Vidra R; Califano R; de Azambuja E; Garrido Lopez P; Guarneri V; Reck M; Moiseyenko V; Martinelli E; Douillard JY; Stahel R; Voest E; Arnold D; Cardoso F; Casali P; Cervantes A; Eggermont AMM; Eniu A; Jassem J; Pentheroudakis G; Peters S; McGregor K; Rauh S; Zielinski CC; Ciardiello F; Tabernero J; Preusser M
    ESMO Open; 2016; 1(6):e000107. PubMed ID: 28255451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal tumor board: an evolving experience in Tehran Cancer Institute.
    Haddad P; Mir MR; Jamali M; Abdirad A; Alikhasi A; Farhan F; Memari F; Sadighi S; Shahi F
    Acta Med Iran; 2013 May; 51(4):270-3. PubMed ID: 23690109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening and surveillance in hereditary gastrointestinal cancers: Recommendations from the European Society of Digestive Oncology (ESDO) expert discussion at the 20th European Society for Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona, June 2018.
    Vangala DB; Cauchin E; Balmaña J; Wyrwicz L; van Cutsem E; Güller U; Castells A; Carneiro F; Hammel P; Ducreux M; van Laethem JL; Matysiak-Budnik T; Schmiegel W
    Eur J Cancer; 2018 Nov; 104():91-103. PubMed ID: 30342310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ESO-ESMO Masterclass in Clinical Oncology: Analysis and Evaluation of the Learning Self-Assessment Test.
    Pavlidis N; Peccatori F; Aapro M; Eniu A; Stahel R; Cervantes A; Cavalli F; Costa A
    J Cancer Educ; 2021 Jun; 36(3):556-560. PubMed ID: 31845109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European Society for Medical Oncology (ESMO) position paper on supportive and palliative care.
    Jordan K; Aapro M; Kaasa S; Ripamonti CI; Scotté F; Strasser F; Young A; Bruera E; Herrstedt J; Keefe D; Laird B; Walsh D; Douillard JY; Cervantes A
    Ann Oncol; 2018 Jan; 29(1):36-43. PubMed ID: 29253069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): a European survey conducted by the European Society for Medical Oncology (ESMO) young oncologists committee.
    Califano R; Karamouzis MV; Banerjee S; de Azambuja E; Guarneri V; Hutka M; Jordan K; Kamposioras K; Martinelli E; Corral J; Postel-Vinay S; Preusser M; Porcu L; Torri V
    Lung Cancer; 2014 Jul; 85(1):74-80. PubMed ID: 24746176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights on personalized cancer treatments: a report from the ESMO Congress.
    Ciardiello F; Jezdic S
    Expert Rev Anticancer Ther; 2011 Jan; 11(1):21-3. PubMed ID: 21166507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controversial issues in early-stage breast cancer: a global collaborative survey, supported by the European Society for Medical Oncology (ESMO).
    Zardavas D; Ades F; Spasojevic IB; Pugliano L; Capelan M; Paesmans M; de Azambuja E; Piccart M
    Ann Oncol; 2014 Aug; 25(8):1558-62. PubMed ID: 24562450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The European Society for Medical Oncology (ESMO) and its activities through the Central Eastern European Task Force.
    Hansen HH; Bjerre-Jepsen M; Hossfeld D
    Ann Oncol; 1999; 10 Suppl 6():9-13. PubMed ID: 10676547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in gastrointestinal cancers.
    Bordry N; Astaras C; Ongaro M; Goossens N; Frossard JL; Koessler T
    World J Gastroenterol; 2021 Jul; 27(28):4493-4503. PubMed ID: 34366620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum.
    van de Velde CJ; Boelens PG; Borras JM; Coebergh JW; Cervantes A; Blomqvist L; Beets-Tan RG; van den Broek CB; Brown G; Van Cutsem E; Espin E; Haustermans K; Glimelius B; Iversen LH; van Krieken JH; Marijnen CA; Henning G; Gore-Booth J; Meldolesi E; Mroczkowski P; Nagtegaal I; Naredi P; Ortiz H; Påhlman L; Quirke P; Rödel C; Roth A; Rutten H; Schmoll HJ; Smith JJ; Tanis PJ; Taylor C; Wibe A; Wiggers T; Gambacorta MA; Aristei C; Valentini V
    Eur J Cancer; 2014 Jan; 50(1):1.e1-1.e34. PubMed ID: 24183379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EURECCA colorectal: multidisciplinary mission statement on better care for patients with colon and rectal cancer in Europe.
    van de Velde CJ; Aristei C; Boelens PG; Beets-Tan RG; Blomqvist L; Borras JM; van den Broek CB; Brown G; Coebergh JW; Cutsem EV; Espin E; Gore-Booth J; Glimelius B; Haustermans K; Henning G; Iversen LH; Han van Krieken J; Marijnen CA; Mroczkowski P; Nagtegaal I; Naredi P; Ortiz H; Påhlman L; Quirke P; Rödel C; Roth A; Rutten HJ; Schmoll HJ; Smith J; Tanis PJ; Taylor C; Wibe A; Gambacorta MA; Meldolesi E; Wiggers T; Cervantes A; Valentini V;
    Eur J Cancer; 2013 Sep; 49(13):2784-90. PubMed ID: 23769991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Policy statement on multidisciplinary cancer care.
    ; Borras JM; Albreht T; Audisio R; Briers E; Casali P; Esperou H; Grube B; Hamoir M; Henning G; Kelly J; Knox S; Nabal M; Pierotti M; Lombardo C; van Harten W; Poston G; Prades J; Sant M; Travado L; Valentini V; van de Velde C; van den Bogaert S; van den Bulcke M; van Hoof E; van den Neucker I; Wilson R
    Eur J Cancer; 2014 Feb; 50(3):475-80. PubMed ID: 24321260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016.
    Dittrich C; Kosty M; Jezdic S; Pyle D; Berardi R; Bergh J; El-Saghir N; Lotz JP; Österlund P; Pavlidis N; Purkalne G; Awada A; Banerjee S; Bhatia S; Bogaerts J; Buckner J; Cardoso F; Casali P; Chu E; Close JL; Coiffier B; Connolly R; Coupland S; De Petris L; De Santis M; de Vries EG; Dizon DS; Duff J; Duska LR; Eniu A; Ernstoff M; Felip E; Fey MF; Gilbert J; Girard N; Glaudemans AW; Gopalan PK; Grothey A; Hahn SM; Hanna D; Herold C; Herrstedt J; Homicsko K; Jones DV; Jost L; Keilholz U; Khan S; Kiss A; Köhne CH; Kunstfeld R; Lenz HJ; Lichtman S; Licitra L; Lion T; Litière S; Liu L; Loehrer PJ; Markham MJ; Markman B; Mayerhoefer M; Meran JG; Michielin O; Moser EC; Mountzios G; Moynihan T; Nielsen T; Ohe Y; Öberg K; Palumbo A; Peccatori FA; Pfeilstöcker M; Raut C; Remick SC; Robson M; Rutkowski P; Salgado R; Schapira L; Schernhammer E; Schlumberger M; Schmoll HJ; Schnipper L; Sessa C; Shapiro CL; Steele J; Sternberg CN; Stiefel F; Strasser F; Stupp R; Sullivan R; Tabernero J; Travado L; Verheij M; Voest E; Vokes E; Von Roenn J; Weber JS; Wildiers H; Yarden Y
    ESMO Open; 2016; 1(5):e000097. PubMed ID: 27843641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The European Society for Medical Oncology 'Magnitude of Clinical Benefit Scale' field-tested in infrequent tumour entities: an extended analysis of its feasibility at the Medical University of Vienna.
    Kiesewetter B; Raderer M; Prager GW; Fuereder T; Marosi C; Preusser M; Krainer M; Locker GJ; Brodowicz T; Zielinski CC
    ESMO Open; 2017; 2(3):e000166. PubMed ID: 28761758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction.
    Giulini SM; Stagnitti F
    Ann Ital Chir; 2019; 90():371-372. PubMed ID: 31815733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do the American Society of Clinical Oncology Value Framework and the European Society of Medical Oncology Magnitude of Clinical Benefit Scale Measure the Same Construct of Clinical Benefit?
    Cheng S; McDonald EJ; Cheung MC; Arciero VS; Qureshi M; Jiang D; Ezeife D; Sabharwal M; Chambers A; Han D; Leighl N; Sabarre KA; Chan KKW
    J Clin Oncol; 2017 Aug; 35(24):2764-2771. PubMed ID: 28574778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.